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investigated according to the patient’s risk of coronary artery disease
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A 45 year old man, who was a non-smoker and did not have
diabetes or hyperlipidaemia, presented to his doctor with chest
discomfort after exercise. There were no relevant findings on
clinical examination and resting electrocardiography (ECG)
results were normal.
What is the next investigation?
Cardiovascular disease is a leading cause of death in the United
Kingdom1; however, most first presentations with chest pain to
primary care have a non-cardiac cause.2 It is important to
establish which patients’ symptoms are caused by obstructive
coronary artery disease, so that these patients can be optimally
managed to control angina and reduce mortality.3 To support
clinical decision making, the National Institute for Health and
Care Excellence (NICE) published guidance in 2010 on the
assessment of patients with chest pain of suspected cardiac
origin.4 This advice proposed a major change in clinical practice
by no longer recommending exercise ECG to investigate stable
chest pain in patients without known coronary artery disease.
Exercise ECG is limited by the need for an interpretable ECG,
the ability of the patient to exercise adequately, and a wide
variability in diagnostic accuracy compared with cardiac
imaging.5 6
The assessment of patients with suspected stable chest pain
begins with a full history, clinical evaluation, and resting ECG.
Subsequent investigation is guided by calculating the pre-test
probability of coronary artery disease using age, sex, risk factors,
and symptom characteristics (see table⇓ and fig 1⇓). The NICE
guidelines stratify patients into three risk groups and recommend
a different strategy for cardiac investigations in each group.
Most patients will have symptomatic coronary artery disease
diagnosed or excluded on the basis of non-invasive cardiac
imaging, with invasive angiography reserved for higher risk
patients being considered for revascularisation.
With increasing use of cardiac computed tomography in lower
risk populations, the effect of radiation dose is an important
consideration, although this might be offset by fewer patients
undergoing nuclear medicine studies. As newer imaging
technology becomes available, radiation dose and diagnostic
accuracy may continue to improve. Typical dose ranges are
given below for tests that use ionising radiation and should be
considered against the annual background dose of about 3 mSv.
Tests recommended for patients with a
low pre-test risk (10-29%)
Computed tomography coronary artery
calcium score
Calcium scoring (sensitivity 98%, specificity 40%) is a screening
test for coronary artery disease that also has prognostic value
for future cardiac events.7 ECG-gated computed tomography
of the heart is performed without contrast medium and a
workstation is used to calculate the calcium (Agatston) score
on the basis of the extent of calcified coronary plaque. Calcium
scoring has a negative predictive value of 99% for obstructive
coronary artery disease in low risk populations, and a normal
study result predicts a 2% cardiac event rate over the next five
years.7 8 If the calcium score is zero then non-coronary causes
of chest pain should be considered. However, obstructive
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Learning points
The National Institute for Health and Care Excellence (NICE) does not recommend exercise electrocardiography for investigating stable
chest pain in patients without known coronary artery disease
NICE guidance recommends that the sequence of imaging tests be determined by the patient’s risk of coronary artery disease
Patients with a pre-test probability of 10-29% for coronary artery disease are initially investigated with coronary artery calcium scoring
using computed tomography
Computed tomography coronary angiography is performed in patients with a calcium score of 1-400 to determine whether there are any
coronary stenoses
Patients with a 30-60% risk are initially investigated with functional cardiac imaging to diagnose flow limiting coronary disease
Invasive coronary angiography, as a first line investigation, is reserved for symptomatic patients with a 61-90% pre-test probability of
coronary artery disease when revascularisation is a treatment option
coronary artery disease may go undetected in younger patients
in whom atherosclerotic plaque has not advanced to the stage
of calcification.8 If the calcium score is 1-400, computed
tomography coronary angiography should be performed
immediately afterwards to assess potential coronary stenoses.
If the calcium score exceeds 400, non-invasive functional
imaging or invasive coronary angiography should be considered
as the next investigation.
Calcium scoring is associated with a relatively low dose of
radiation (≤3 mSv), is rapid and easy to perform, and does not
require heart rate control. Calcified plaques are often not flow
limiting due to remodelling of the vessel wall but are a marker
for the presence of non-calcified plaques elsewhere.9 Around
17% of patients attending a rapid access chest pain clinic will
be referred for calcium scoring. The test will effectively rule
out symptomatic coronary artery disease in at least 70% of these
patients.10
Computed tomography coronary angiography
Computed tomography coronary angiography (sensitivity 98%,
specificity 92%) is used to determine whether patients with a
calcium score of 1-400 have obstructive coronary artery
disease.11 Imaging is performed using an ECG-gated computed
tomography scanner with at least 64 slices during a timed bolus
of intravenous contrast medium. Three dimensional images of
the angiogram are reconstructed on a workstation to visualise
coronary stenoses caused by calcified or non-calcified plaque.
The positive predictive value of this technique for detecting a
coronary stenosis of 50% or more is 91%, with a negative
predictive value of 83%.12 In patients with a calcium score of
less than 100, the negative predictive value rises to 93%.13 If
there is doubt about the importance of a stenosis then functional
cardiac imaging can be considered.
Patients often require heart rate control with oral or intravenous
cardioselective β blockers andmay be given sublingual glyceryl
trinitrate for coronary vasodilatation. β blockers should be used
with caution in patients with severe asthma or decompensated
heart failure. NICE recommends using next generation scanners
for patients who are difficult to image with conventional 64
slice equipment because they offer higher image resolution with
lower radiation exposure and are cost effective.14 15 Radiation
doses of less than 1 mSv are achievable with these scanners in
non-obese patients with stable heart rates, but in clinical practice
doses typically range between 2 and 12 mSv.16
Tests recommended for patients with a
medium pre-test risk (30-60%)
Functional cardiac imaging
Functional cardiac imaging uses pharmacological agents to
identify flow limiting coronary disease. It is the first line
investigation for patients with a 30-60% pre-test probability of
coronary artery disease. Functional imaging may be performed
in several different ways andNICE recommends four commonly
available methods. The choice of investigation will largely
depend on local availability and patient suitability, but it should
also be informed by diagnostic accuracy and any potential risks.
Perfusion imaging
In patients with flow limiting coronary disease, an intravenous
vasodilator (such as adenosine, regadenoson, or dipyridamole)
will increase the difference between perfusion of normal
myocardium and that supplied by a stenosed artery. This can
be visualised withmyocardial perfusion scintigraphy (sensitivity
91%, specificity 78%), which uses a tracer taken up by cardiac
myocytes and imaged with a gamma camera. Images acquired
during vasodilator stress and at rest are compared to assess
whether perfusion is impaired within a coronary artery territory.17
Cardiac magnetic resonance imaging, where first pass contrast
enhanced imaging of the heart is performed during a vasodilator
infusion, can also be used to assess myocardial perfusion
(sensitivity 90%, specificity 79%).18 This test has a higher
negative predictive value thanmyocardial perfusion scintigraphy
(91% v 79%) and it avoids exposure to radiation (6-9 mSv).19
Adenosine is contraindicated in severe asthma and in patients
with second or third degree heart block. Cardiac magnetic
resonance imaging is not suitable for patients with an
incompatible pacemaker or claustrophobia. Patients should not
ingest caffeine in the 24 hours before the test due to competitive
inhibition of adenosine.
Wall motion imaging
The sympathomimetic drug dobutamine can be used to induce
a regional wall motion abnormality within ischaemic
myocardium during continuous imaging of the left ventricle.
These abnormalities may be visualised using echocardiography
(sensitivity 87%, specificity 84%) or cardiacmagnetic resonance
(sensitivity 91%, specificity 81%).20 21 Image quality for
echocardiographymay be improved in patients who are difficult
to image with intravenous contrast agents.22 Contraindications
to dobutamine include severe aortic stenosis and obstructive
hypertrophic cardiomyopathy. Major complications occur in
1.7 per 1000 patients, with the most common serious event
being sustained ventricular tachycardia.23
Tests recommended for patients with a
high pre-test risk (61-90%)
Invasive catheter angiography
If the estimated likelihood of coronary artery disease is 61-90%,
or if functional or anatomical coronary imaging is
non-diagnostic, patients who would be considered for
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revascularisation are offered invasive coronary angiography. A
catheter is passed through the common femoral or radial artery
and used to selectively visualise the coronary arteries with
contrast medium during fluoroscopy. This is considered the
gold standard investigation for assessing the lumen of the
coronary arteries. As well as diagnosing coronary artery disease,
patients may proceed to coronary stenting to relieve anginal
symptoms if a suitable stenosis is identified. It may be difficult
to define the importance of an intermediate stenosis on an
angiogram, so the flow limiting effect can be assessed by using
a pressure recording catheter.24 The typical radiation dose for
diagnostic coronary angiography is 3-6 mSv. The overall
complication rate is 7.4 per 1000, with a mortality rate of 0.7
per 1000.25 The most common complications are arrhythmias,
vascular injury, and myocardial ischaemia.
Outcome
On the basis of age, sex, risk factors, and symptoms, the
patient’s pre-test probability of coronary artery disease was 21%
and he was referred for calcium scoring. The calcium score was
11 (fig 2⇓) and he proceeded to computed tomography coronary
angiography, which identified a 70% stenosis of the left anterior
descending coronary artery (fig 3⇓). Adenosine stress perfusion
cardiac magnetic resonance imaging showed reduced perfusion
of the septumwithin the territory of the left anterior descending
coronary artery. He was managed for stable angina on the basis
of these findings (fig 4⇓).
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Table
Table 1| Proportion of people estimated to have coronary artery disease according to typicality* of symptoms, age, sex, and risk (high or
low).4 Values are proportion of people at each mid-decade age with clinically relevant CAD†
Typical anginaAtypical anginaNon-anginal chest pain‡
Age
(years)
WomenMenWomenMenWomenMen
High riskLow riskHigh riskLow riskHigh riskLow riskHigh riskLow riskHigh riskLow riskHigh risk§Low risk§
7810883039259819135335
79209251435702122247945
8238958047107945254592355
8456979351208671299694965
*Typical angina pain is constricting discomfort in the front of the chest, neck, shoulders, jaw, or arms, which is precipitated by physical exertion and relieved by
rest or glyceryl trinitrate within about 5 minutes. Atypical angina pain has two of the features of typical angina. Non-angina pain has none or one of the features of
typical angina pain.
†If there are resting ST-T changes or Q waves on electrocardiography, the likelihood of CAD is higher in all patient groups; for men over 70 years with atypical or
typical symptoms assume a risk estimate of >90%; for women over 70 years, assume an estimate of 61-90% unless the woman is at high risk and has typical
symptoms, in which case a risk of >90% should be assumed.
‡These patients are not routinely investigated for CAD unless there is a high clinical suspicion.
A diagnosis is made by clinical assessment alone in patients with a pre-test probability of <10% or >90%.
§High risk=diabetes, smoking or hyperlipidaemia (total cholesterol >6.47 mmol/L; 1 mmol/L=38.61 mg/dL); low risk=none of the above three risk factors.
CAD=coronary artery disease.
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Figures
Fig 1Diagnostic pathways for the investigation of stable chest pain in patients without known coronary artery disease based
on pre-test probability.4 CT=computed tomography; CMR=cardiac magnetic resonance imaging
Fig 2Computed tomography calcium scoring showing calcified plaque that has been highlighted in the left anterior descending
coronary artery (arrow)
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Fig 3Computed tomography coronary angiography showing stenosis of the left anterior descending coronary artery (arrows)
near the origin of the first diagonal branch on a whole heart image (left) and a curved reconstruction (right)
Fig 4 First pass perfusion cardiac magnetic resonance imaging performed during and after an adenosine infusion. An
inducible perfusion defect is present during stress (left) within the territory of the left anterior descending coronary artery
(arrows) compared with normal perfusion at rest (right)
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